Sarah obtained her Master’s degree in Biochemistry from the University of Montreal, and is pursuing a Diploma in Management from HEC Montreal. Her research interests reside in developing and characterizing new Caenorhabditis elegans models to study rare, genetic disorders, using them to generate insights into disease pathologies, and as drugs screening tools.he close partnerships with rare disease families and foundations helps Sarah see the direct impact of her work and keep an eye on how she can support them through the personalized drug discovery process. Modelis’ company values, such as integrity, passion, and social responsibility, align well with her personal and professional values, making her a perfect fit to Modelis’ team